nevirapine has been researched along with cysteine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Arakaki, R; Baba, M; Jinno, S; Nakashima, H; Premanathan, M; Ramanan, S; Yamashita, S | 1 |
Boucher, CA; de Jong, MD; Lange, JM; Schuurman, R | 1 |
Back, DJ; Earnshaw, CJ; French, NS; Howarth, A; Jenkins, RE; Meng, X; Naisbitt, DJ; Park, BK | 1 |
1 review(s) available for nevirapine and cysteine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for nevirapine and cysteine
Article | Year |
---|---|
3-(5-Dimethylamino-1-naphthalenesulphonyl)-2-(3-pyridyl)thiazolidine (YHI-1) selectively inhibits human immunodeficiency virus type 1.
Topics: Animals; Anti-HIV Agents; Antiviral Agents; Cell Line; Cysteine; Drug Resistance; Fishes; HIV Core Protein p24; HIV Protease; HIV-1; Humans; Molecular Structure; Naphthalenes; Nevirapine; Reverse Transcriptase Inhibitors; Thiazoles; Thiazolidines; Virus Replication | 1998 |
Replication of a pre-existing resistant HIV-1 subpopulation in vivo after introduction of a strong selective drug pressure.
Topics: Codon; Cysteine; Drug Resistance, Microbial; Follow-Up Studies; HIV Infections; HIV-1; Humans; Mutation; Nevirapine; Polymerase Chain Reaction; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; Tyrosine; Viral Load | 1996 |
Detection of drug bioactivation in vivo: mechanism of nevirapine-albumin conjugate formation in patients.
Topics: Adult; Aged; Anti-HIV Agents; Biotransformation; Cysteine; Glutathione S-Transferase pi; Histidine; HIV Infections; HIV-1; Humans; Middle Aged; Nevirapine; Protein Binding; Serum Albumin | 2013 |